Pioglitazone is an effective treatment for patients with post-stroke depression combined with type 2 diabetes mellitus

Experimental and Therapeutic Medicine

Volumn 10, Issue 3, 2015, Pages 1109-1114

  Hu, Yaozhi ^a   Xing, Haiyan ^b   Dong, Xiaomeng ^a   Lu, Wenxian ^a   Xiao, Xinxing ^a   Gao, Lilin ^a   Cui, Minghu ^c   Chen, Jinbo ^a  

^a Affiliated Hospital of Binzhou Medical University   (China)

^b Binzhou People's Hospital   (China)

^c BINZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Antidepressant; Pioglitazone; Post stroke depression; Type 2 diabetes mellitus

Indexed keywords

FLUOXETINE; GLUCOSE; INSULIN; METFORMIN; PIOGLITAZONE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DEPRESSION; FEMALE; GLUCOSE BLOOD LEVEL; HAMILTON DEPRESSION RATING SCALE; HUMAN; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL;

EID: 84937703064     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2015.2593     Document Type: Article

References (20)

1. Morris PL, Robinson RG and Raphael B: Prevalence and course of depressive disorders in hospitalized stroke patients. Int J Psychiatry Med 20: 349-364, 1990.
2. Turner A, Hambridge J, White J, et al: Depression screening in stroke: a comparison of alternative measures with the structured diagnostic interview for the diagnostic and statistical manual of mental disorders, fourth edition (major depressive episode) as criterion standard. Stroke 43: 1000-1005, 2012.
3. Smith RC, Jin H, Li C, et al: Effects of pioglitazone on metabolic abnormalities, psychopathology, and cognitive function in schizophrenic patients treated with antipsychotic medication: a randomized double-blind study. Schizophr Res 143: 18-24, 2013.
4. Kashani L, Omidvar T, Farazmand B, et al: Does pioglitazone improve depression through insulin-sensitization? Results of a randomized double-blind metformin-controlled trial in patients with polycystic ovarian syndrome and comorbid depression. Psychoneuroendocrinology 38: 767-776, 2013.
5. Kemp DE, Ismail-Beigi F, Ganocy SJ, et al: Use of insulin sensitizers for the treatment of major depressive disorder: a pilot study of pioglitazone for major depression accompanied by abdominal obesity. J Affect Disord 136: 1164-1173, 2012.
6. Sepanjnia K, Modabbernia A, Ashrafi M, Modabbernia MJ and Akhondzadeh S: Pioglitazone adjunctive therapy for moderat e-t o-severe maj or depressive di sorder: Randomi zed double-blind placebo- controlledtrial. Neuropsychopharmacology 37: 2093-2100, 2012.
7. Pettersson A, Bengtsson Boström K, Gustavsson P and Ekselius L: Which instruments to support diagnosis of depression have sufficient accuracy? A systematic review. Nord J Psychiatry: March 3, 2015 (Epub ahead of print).
8. Jia J and Chen S (eds): Brain vessel disease. In: Neurology (7th edition). People's Medical Publishing House, Beijing, China, p199, 2013.
9. Zimmerman M, Martinez JH, Young D, Chelminski I and Dalrymple K: Severity classification on the Hamilton Depression Rating Scale. J Affect Disord 150: 384-388, 2013.
10. Schneider MA and Schneider MD: Recognizing poststroke depression. Nursing 42: 60-63, 2012.
11. Poynter B, Shuman M, Diaz-Granados N, Kapral M, Grace SL and Stewart DE: Sex differences in the prevalence of post-stroke depression: a systematic review. Psychosomatics 50: 563-569, 2009.
12. Kemp DE, Ismail-Beigi F and Calabrese JR: Antidepressant response associated with pioglitazone: support for an overlapping pathophysiology between major depression and metabolic syndrome. Am J Psychiatry 166: 619, 2009.
13. Salehi-Sadaghiani M, Javadi-Paydar M, Gharedaghi MH, et al: NMDA receptor involvement in antidepressant-like effect of pioglitazone in the forced swimming test in mice. Psychopharmacology (Berl) 223: 345-355, 2012.
14. Sadaghiani MS, Javadi-Paydar M, Gharedaghi MH, Fard YY and Dehpour AR: Antidepressant-like effect of pioglitazone in the forced swimming test in mice: The role of PPAR-gamma receptor and nitric oxide pathway. Behav Brain Res 224: 336-343, 2011.
15. Tamayo T, Jacobs DR Jr, Strassburger K, et al: Race-and sex-specific associations of parental education with insulin resistance in middle-aged participants: the CARDIA study. Eur J Epidemiol 27: 349-355, 2012.
16. Austin AW, Gordon JL, Lavoie KL, Arsenault A, Dasgupta K and Bacon S: Differential association of insulin resistance with cognitive and somatic symptoms of depression. Diabet Med 31: 994-1000, 2014.
17. Hardy OT, Czech MP and Corvera S: What causes the insulin resistance underlying obesity? Curr Opin Endocrinol Diabetes Obes 19: 81-87, 2012.
18. TODAY Study Group: Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and ß-cell function in TODAY. Diabetes Care 36: 1749-1757, 2013.
19. Badaru UM, Ogwumike OO, Adeniyi AF and Olowe OO: Variation in functional independence among stroke survivors having fatigue and depression. Neurol Res Int 2013: 842-980, 2013.
20. Robinson RG and Spalletta G: Poststroke depression: a review. Can J Psychiatry 55: 341-349 2010.